Cargando…
Overcoming the Limitations of Stem Cell-Derived Beta Cells
Great advances in type 1 diabetes (T1D) and type 2 diabetes (T2D) treatment have been made to this day. However, modern diabetes therapy based on insulin injections and cadaveric islets transplantation has many disadvantages. That is why researchers are developing new methods to regenerate the pancr...
Autores principales: | Karimova, Mariana V., Gvazava, Inessa G., Vorotelyak, Ekaterina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221417/ https://www.ncbi.nlm.nih.gov/pubmed/35740935 http://dx.doi.org/10.3390/biom12060810 |
Ejemplares similares
-
Type 2 Diabetes Mellitus: Pathogenic Features and Experimental Models in Rodents
por: Gvazava, I. G., et al.
Publicado: (2022) -
Extracellular Matrix as a Regulator of Epidermal Stem Cell Fate
por: Chermnykh, Elina, et al.
Publicado: (2018) -
Derivation of Hair-Inducing Cell from Human Pluripotent Stem Cells
por: Gnedeva, Ksenia, et al.
Publicado: (2015) -
Self-Renewal of Stem Cells
por: Terskikh, V.V., et al.
Publicado: (2009) -
Pathogenesis of Type 1 Diabetes Mellitus and Rodent Experimental Models
por: Gvazava, I. G., et al.
Publicado: (2018)